Simulations of cilengitide PK profiles in pediatric population by means of allometric scaling: Reliability and support to BSA-based dose adjustment strategy.

9548 Background: Cilengitideis a selective αvβ3/αvβ5 integrin inhibitor in clinical development for the treatment of various types of solid tumors. In this study, a population pharmacokinetic (PK)...